Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ryuta Terao"'
Autor:
Hiroko Asai, Toshio Okamoto, Ken Nagaya, Ryuta Terao, Fumikatsu Nohara, Hiroshi Azuma, Mitsumaro Nii
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(3)
Introduction Although imatinib is the first-line of therapy for Philadelphia chromosome (Ph)-positive chronic myeloid leukemia (CML), in Japan, it is recommended by the manufacturer that lactating women treated with imatinib mesylate for CML should d
Autor:
N Harada, Yoshio Yamaoka, Ryuta Terao, Takashi Nitta, Etsuro Hatano, Yuji Iimuro, Tetsuya Uehara, Masanori Yoshida, Naritaka Yamamoto
Publikováno v:
European Surgical Research. 34:251-259
The aim of this study was to target Kupffer cells (KCs) selectively and efficiently by the intraportal injection of fusigenic cationic liposomes with hemagglutinating virus of Japan components (HVJ cationic liposomes). Phosphorothioate FITC-oligodeox
Autor:
Yoshio Yamaoka, Naritaka Yamamoto, Tetsuya Uehara, Takashi Nitta, Masanori Yoshida, Yuji Iimuro, Etsuro Hatano, Ryuta Terao
Publikováno v:
The Journal of surgical research. 102(2)
Background. Proliferative cholangitis (PC) associated with hepatolithiasis results in stricture of the main bile ducts and is a major cause of residual and/or recurrent stones after repeated treatment for hepatolithiasis. The transcription factor E2F
Autor:
Etsuro Hatano, Yoshio Yamaoka, Yasufumi Kaneda, Tetsuya Uehara, Kazuo Honda, Ryuta Terao, Yuji Iimuro, Masayuki Yamamoto, Naritaka Yamamoto
Publikováno v:
Journal of hepatology. 30(5)
Background/Aims: The ability to transfer foreign genes into the biliary tract would be useful for the treatment of biliary tract diseases, including cancer, cystic fibrosis and other genetic diseases. To introduce a foreign gene precisely into the ra
Publikováno v:
Hepatology (Baltimore, Md.). 28(3)
Proliferative cholangitis (PC) associated with hepatolithiasis develops the stricture of main bile ducts, and is the main cause of residual and/or recurrent stones after repeated treatments for hepatolithiasis. The aim of this study was to inhibit PC
Autor:
Hiroshi TANIMURA, Keisuke YOSHIDA, Nobuaki KOBAYASHI, Kazuhisa UCHIYAMA, Yuzi USUI, Naohiko NISHIMURA, Kazue OZAWA, Tsuguo KITAMURA, Ken IZUKURA, Hisashi TAMURA, Shinichi FUJITA, Motoichi SETOYAMA, Sumio MUKAIHARA, Mitsutoshi YUNG, Koichiro TAMURA, Ryuta TERAO, Masanori MAJIMA, Yoshio MANIWA, Kimio HENMI, Yuzo YAMAMOTO, Izumi MARUYAMA, Hiroshi TAKAHASHI, Tohru SAITO, Hitoshi KATO, Keisuke MARUYAMA, Nobuo SAITO
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 61:681-703